TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/16/04 12:06 | 8/13/04 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Gee Edwin A | NY | D | S.d | -385 | 54.99 | 0 | -7 | -66 | 4 | D | |||||||||||||||
5/17/04 16:40 | 5/14/04 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Gee Edwin A | NY | D | S.d | -784 | 78.35 | 0 | -10 | -74 | 4 | D | |||||||||||||||
8/25/03 17:10 | 8/25/03 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Gee Edwin A | NY | D | S | -89 | 35.61 | 0 | -3 | -45 | 3 | D | |||||||||||||||
8/21/03 10:09 | 8/19/03 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Gee Edwin A | NY | D | S | -87 | 34.81 | 0 | -3 | -45 | 3 | D | |||||||||||||||
8/18/03 16:41 | 8/14/03 | OSIP | Osi Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Gee Edwin A | NY | D | S | -161 | 32.26 | 0 | -5 | -63 | 3 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |